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author and source are credited.Developmental plasticity, cell fate
specification and morphogenesis
in the early mouse embryo
Ivan Bedzhov, Sarah J. L. Graham, Chuen Yan Leung
and Magdalena Zernicka-Goetz
Department of Physiology, Development and Neuroscience, University of Cambridge, Downing Street,
Cambridge CB2 3DY, UK
A critical point in mammalian development is when the early embryo
implants into its mother’s uterus. This event has historically been difficult to
study due to the fact that it occurs within the maternal tissue and therefore
is hidden from view. In this review, we discuss how the mouse embryo is
prepared for implantation and the molecular mechanisms involved in
directing and coordinating this crucial event. Prior to implantation, the
cells of the embryo are specified as precursors of future embryonic and
extra-embryonic lineages. These preimplantation cell fate decisions rely on a
combination of factors including cell polarity, position and cell–cell signalling
and are influenced by the heterogeneity between early embryo cells. At the
point of implantation, signalling events between the embryo and mother,
and between the embryonic and extraembryonic compartments of the
embryo itself, orchestrate a total reorganization of the embryo, coupled with
a burst of cell proliferation.Newdevelopments in embryo culture and imaging
techniques have recently revealed the growth and morphogenesis of the
embryo at the time of implantation, leading to a new model for the blastocyst
to egg cylinder transition. In this model, pluripotent cells that will give rise to
the fetus self-organize into a polarized three-dimensional rosette-like structure
that initiates egg cylinder formation.1. Heterogeneity guides preimplantation cell fate decisions
(a) Regulative development of the preimplantation embryo
Mouse preimplantation development involves the sequential division of the fer-
tilized egg into progressively smaller cells, or blastomeres, over the first four
and a half days of life. This process results in the formation of a hollow ball
of cells, the blastocyst, which is capable of implanting into the maternal uterine
wall and comprises the necessary cell types to give rise to both embryonic
and extraembryonic tissues in later development (figure 1). The blastocyst is
organized into three distinct cell lineages by the time of implantation: the extra-
embryonic trophectoderm (TE) and primitive endoderm (PE), and the
embryonic epiblast (EPI). The specification of these three cell types is achieved
through two ‘cell fate decisions’. In the first cell fate decision, two major waves
of asymmetric cell divisions at the 8- to 16- and 16- to 32-cell transitions and a
minor wave at the 32- to 64-cell transition generate outside and inside cells that
differ in their cellular properties, position within the embryo and their fate
[1–3]. Outside cells will differentiate into TE, the precursor lineage of the pla-
centa. Inside cells form the pluripotent inner cell mass (ICM) and will be further
separated in the second cell fate decision into the differentiating PE that predo-
minantly gives rise to the yolk sac, and the pluripotent EPI that is the precursor
of the future fetus. The correct specification and organization of these different
cell types is essential for development of the embryo beyond implantation, and
preimplantation postimplantation >peri-
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Figure 1. Overview of early mouse development. Embryonic and extraembryonic cells are specified in the preimplantation embryo by two cell fate decisions. In the
first cell fate decision, waves of cell divisions create inside and outside cells. Outside cells give rise to extraembryonic trophectoderm (TE), while inside cells form the
pluripotent inner cell mass (ICM). In the second cell fate decision, cells of the ICM are segregated into the extraembryonic PE and the pluripotent epiblast (EPI) that
will later give rise to all tissues of the body. These fate decisions are influenced but not determined by heterogeneity between individual cells within the embryo
that is established by the 4-cell stage (shown by different shading of cells). At E4.5, the embryo initiates implantation and over the next 24 h invades the maternal
tissues, rapidly proliferates and transforms into an egg cylinder. This new form serves as a foundation for EPI patterning, laying down the body axis and establish-
ment of the germ layers. ExE, extraembryonic ectoderm; PE, primitive endoderm; VE, visceral endoderm.
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2how they are specified from a small cluster of seemingly
identical cells is a fundamental question of mammalian
developmental biology.
Understanding how cell fate is specified in the pre-
implantation embryo has been complicated by the flexibility
of early mammalian development. Early experiments manip-
ulating the preimplantation mouse embryo demonstrated
that its development is regulative, that is it can adapt
and compensate for perturbations in the positions and num-
bers of cells. Removing blastomeres, rearranging them or
making chimaeras of more than one embryo can all result
in the formation of a blastocyst, indicating a flexibility
in cell potential until the 32-cell stage [4–7]. This ability
of cells in the embryo to modulate their fate in response to
contextual changes led to the hypothesis that early develop-
ment was driven by entirely random processes, with all
cells equally able to contribute to any lineage [8]. However,
this raises the question—if all cells are the same, how do
they know what to do? The most obvious way in which
cells can be different from each other is their position
within the embryo, with outside cells developing into TE,
surface ICM cells becoming PE and deep ICM cells becom-
ing pluripotent EPI. Position can indeed alter cell fate
[7,9–11] and this position model is attractive in its simplicity.
However, recent discoveries indicate that cell position is not
the only factor involved in controlling cell fate in the mouse
embryo. For example, it was discovered that cell fate can
be altered in the first cell fate decision by modifying the
expression of specific genes, which in turn leads to a
change in cell position [12]. The primary role of position in
the second cell fate decision has also been challenged by
the observation that the precursors of the PE and EPI are
initially mixed within the ICM, before being sorted into
their correct positions by active cell migration and selective
apoptosis [13–15]. These findings demonstrated that position
is not the only factor driving both the first and the second
cell fate decision and suggested that rather than cells becom-
ing different from each other in response to their positions,they are already biased towards certain fates before they
reach distinct positions.
(b) When do cells first become different from
each other?
Recent advances in technologies that allow the tracking of
individual cells throughout preimplantation development
have provided insights into when these early differences
arise. The first experiments that involved tracking cells
labelled with in vivo markers suggested that blastomeres
are different from each other already at the 2-cell stage. By
non-invasively labelling blastomeres or marking the zona
pellucida after the first cleavage division, it was demon-
strated that both 2-cell stage blastomeres contribute to all
blastocyst lineages, but they are biased towards contributing
more to either an extraembryonic or an embryonic part of the
embryo [16–18]. This view was challenged by reports that
concluded the embryonic/extraembryonic axis of the blasto-
cyst was determined by physical constraints of the embryo
within the zona pellucida rather than any inherent differ-
ences between blastomeres [19,20]. More information on
this subject was provided by the discovery that 4-cell stage
blastomeres differ in their developmental potential depend-
ing both on whether they are daughters of the first or
second-dividing 2-cell blastomere and on their division
orientation with respect to the animal–vegetal axis of the
egg. It was demonstrated that one blastomere that contains
the most vegetal portion of the embryo is biased to give
rise to extraembryonic lineages rather than embryonic ones
[21,22]. The reduced developmental potential of this cell
was found to relate to lower levels of histone H3 methylation
on specific arginine residues, demonstrating for the first time
that 4-cell stage blastomeres differ at an epigenetic level [23].
These results were disputed [19,24] but a recent genetic
lineage tracing study using Rainbow mice confirms a signifi-
cant lineage bias being initiated at the 4-cell stage [25].
In addition, several studies have identified heterogeneous
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meres [26,27], providing further evidence that individual
cells are different from each other already at this early devel-
opmental stage. Studies tracking the fate of individual cells
have begun to uncover how these early differences might
influence cell fate decisions. ypublishing.org
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The first molecular difference to be identified between cells at
the 4-cell stage was differences in the levels of arginine
methylation of histone H3, specifically R26 and 17. This
methylation was found to be highest in cells destined to con-
tribute to the ICM and lowest in the cells that will give rise to
the TE. In agreement with this, high H3 methylation levels
correlates with increased expression of Nanog and Sox2
[23]. The cells biased towards contributing to extraembryonic
lineages preferentially divide symmetrically and thereby
avoid contributing to the ICM [28]. A clue to how division
orientation could be influenced by the developmental history
of cells came from the observation that at the 8-cell stage
some cells express higher levels of the TE-specific transcrip-
tion factor Cdx2 [29–31]. Tracing the history of these cells
revealed that they are derived from the vegetal 4-cell blasto-
mere known to be biased towards an extraembryonic fate
[31]. Consistently, up- or downregulating Cdx2 expression
level affects division orientation, most likely by influencing
the apical–basal polarity of the cell [31]. In this way, the het-
erogeneity of cells in the embryo provides a mechanism by
which blastomeres can be influenced when undertaking the
first cell fate decision.
Heterogeneity between cells also influences the second
cell fate decision. In the early embryonic day (E) 3.5 blasto-
cyst, ICM cells express markers of the PE (Gata6) and EPI
(Nanog) in a mosaic ‘salt and pepper’-like distribution,
with this early gene expression pattern identifying the pre-
cursors of each lineage [13,15,29]. Without this coordinated
expression of Gata6 and Nanog in the ICM, correct speci-
fication of the PE and EPI fails [13,32]. Whether this
heterogeneity results from stochastic fluctuations in gene
expression or whether ICM cells are different from each
other due to their developmental history has only recently
been possible to address. Several independent studies
demonstrated that the fate of ICM cells is biased by the
timing of cell internalization, with inside cells generated ear-
lier more likely to contribute to EPI and those arriving inside
later biased to form PE [2,33,34]. By generating the ICM in
sequential waves of asymmetric divisions, the embryo has
an in-built mechanism for creating a heterogeneous ICM
cell population. This bias relates to the reciprocal expression
of fibroblast growth factor (Fgf)4 ligand and Fgf receptor
(Fgfr)2 in the precursors of the EPI and PE respectively,
with cells internalized earlier upregulating Fgf4 and those
internalized later expressing higher levels of Fgfr2 [33,35].
Single-cell RNA sequencing of isolated ICM cells confirmed
differential expression of Fgf ligands and receptors to be a
feature of the ICM prior to the ‘salt and pepper’ expression
of Gata6 and Nanog and highlighted the importance of
heterogeneity within the ICM for the establishment of two
different cell fates [8]. The importance of this internaliz-
ation-time bias depends on the ICM composition, having
the greatest influence when both waves of asymmetric div-
isions contribute equally to the ICM, most likely due to theratio of cells expressing Fgf4 and Fgfr2 in the embryo [33,35].
This context-dependent bias demonstrates howposition, signal-
ling and inherent heterogeneities all influence cell fate decisions.
Heterogeneity therefore provides biases that guide, but do
not determine, cell fate decisions thus allowing flexibility. Strik-
ingly, without this heterogeneity, the developmental potential
of embryos canbecompromised, as seen in chimaerasgenerated
from ‘like’ 4-cell stage blastomeres [21,36].2. The molecular basis of preimplantation cell
fate specification
(a) Transcriptional identities of the trophectoderm
and inner cell mass
Several transcription factors identified as important for ICM
specification, such as Oct4 [37], Nanog [38] and Sox2 [39],
are initially expressed in all cells of the morula, with their
expression gradually becoming restricted to the ICM. By con-
trast, the transcription factors important for TE specification
are restricted earlier, at the 8- to 16-cell transition. These mar-
kers include Cdx2 [40,41], Eomes [42] and Gata3 [43]. The TE
and ICM identities are incompatible with each other and
indeed Cdx2 and Oct4 reciprocally inhibit each other [41].
One of the important functions of the TE is the formation
of the blastocyst cavity, the location of which determines the
embryonic–abembryonic axis of the embryo. As the TE
matures, it forms a polarized epithelium with intercellular
junctions creating a permeability seal between the cells that
allows for cavity expansion [44–47]. The initiation of cavity
formation does not depend upon cell number but rather the
formation of these junctions [48,49], and the cavity typically
forms in regions where the outside cells are daughters of
symmetric 16- to 32-cell divisions [28]. Cavitation is initiated
around the 32-cell stage by diffusion of water across osmotic
gradients and the transport of water through aquaporins on
the apical and basolateral sides of TE cells [50,51]. The
exact regulation of this process still remains unknown.
To understand cell fate specification, it is critical to deter-
mine how the reciprocity in the expression pattern between
TE and ICM markers is first established. Activation of the
TE fate programme in outside cells is regulated by the tran-
scription factor Tead4, depletion of which leads to the
earliest thus far reported embryonic lethal TE phenotype
[52,53]. Although elimination of Tead4 does not affect
either cell adhesion or polarization, expression of the TE
transcription network is compromised and expression of
Oct4 in outside cells is maintained [52,53]. Highly homolo-
gous family members Tead1 and Tead2 (but not Tead3) are
also expressed during preimplantation stages, but do not
appear to have a role before implantation [54,55], indicating
that Tead4 is a non-redundant master regulator of the TE
fate. This importance of Tead4 led to an expectation that its
expression would be restricted to TE progenitors, however
it was found to be expressed constitutively in not only outside
but also inside cells of the blastocyst [53]. A further layer of
regulation must therefore activate Tead4 selectively in TE pro-
genitors. In the preimplantation embryo, Tead4 activity
requires the two homologous transcriptional co-activators
Yap and Taz, which are regulated by the core Hippo signall-
ing pathway kinase Lats1/2 [56]. An active Hippo pathway
prevents Yap and Taz from reaching the nucleus and,
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4consequently, Tead4 activity is switched off and its target genes
silenced. Yap and Taz are also expressed uniformly in the
embryo but have distinct intracellular distribution: they are
nuclear in outside cells, where Tead4 is active and the TE pro-
gramme is activated, and cytoplasmic in inside cells, where
Tead4 is inactive resulting in an ICM programme. Neither
Yap nor Taz alone are essential for preimplantation develop-
ment [57–59], but Yap2/2; Taz2/2 double mutants die
before the 16- to 32-cell stage [56], resembling the Tead42/2
phenotype. As expected Lats12/2; Lats22/2 double mutant
embryos have increased nuclear Yap and express Cdx2 in
inside cells [56]. The differential localization of Yap and Taz
in inside and outside cells is therefore critical for the activation
of specific transcriptional programmes in the first cell fate
decision. The activation of the TE fate programme in outside
cells is reinforced by a positive feedback loop in which the
expression of Cdx2 inhibits the expression of pluripotency
genes and positively regulates its own expression [41]. Inside
cells are at least partially protected from the activation of this
programme by the exclusion of Cdx2 mRNA from inside
daughter cells of asymmetric cell divisions [60]. This asym-
metric inheritance of Cdx2 transcripts has been shown to be
dependent upon the apical localization of Cdx2 mRNA as
the 8-cell stage blastomeres develop apical–basal polarity. Dis-
ruption of this mRNA localization leads to expression of Cdx2
in inside cells and a reduction in the number of pluripotent EPI
cells [60], which compromises developmental potential [36].
Together, these findings highlight the importance of creating
cells with different positional identities for the generation of
separate embryonic and extraembryonic lineages. A key ques-
tion remaining, however, is how positional information is
connected to the differential localization of Hippo pathway
components in inside and outside cells.
(b) Polarity translates positional cues into molecular
differences
An intrinsic difference between inside and outside cells is
cell–cell contact. At the 8-cell stage, all cells are positionally
equivalent. The embryo then undergoes compaction, in
which the blastomeres adhere tightly to each other, and the
cells become polarized along their apical–basal axis. When
inside cells are generated, they lose polarization and encoun-
ter uniform cell–cell contacts. By contrast, outside cells
remain polarized and have asymmetric cell–cell contacts,
with an apical domain forming at the bare patch of mem-
brane that is not in contact with neighbouring cells. Apical
polarity factors such as Par3 and atypical protein kinase C
(aPKC) accumulate at this apical domain and interference
with components of the Par complex has been shown to
affect both cell position and cell fate [12,61]. This discovery,
combined with the observation that polarity and cell adhesion
are not affected in Tead42/2 embryos [53], indicates that the
apical polarity complex is upstream of the TE fate programme.
The basolateral domain, where cells are in direct contact with
each other, contains adherens junctions (AJs) that mediate cell
adhesion via E-cadherin. In E-cadherin mutants, cell adhesion
is compromised and the apical domain extends over the
entire cell [62]. Embryos lacking both maternal and zygotic E-
cadherin have more Cdx2-positive cells, suggesting that when
all cells of the embryo are polarized, the majority will take on
a TE fate. Indeed, in these E-cadherin maternal/zygotic
mutant embryos, cells with membrane-enriched aPKC shownuclear localization of Yap and express Cdx2, independent of
their position within the embryo [62]. This implies that the
establishment of apical polarity is dominant over cell position in
cell fate. Similarly, the asymmetric cell–cell contact of isolated
ICMs leads to polarization [62] and TE cells are regenerated
[11,63], demonstrating that ICM cells retain plasticity and can
change their fate in response to new positional information.
Cell–cell contact can therefore be viewed as an inhibitor of
apical domain formation and the internalization of cells by
asymmetric divisions as a mechanism by which embryonic
cells can be protected from differentiation cues. If part of the
membrane loses cell–cell contact, as is the case in outside
cells, an apical domain is established, leading to the activation
of a dominant TE fate programme.
But what is the connection between theHippo pathway and
polarity? Recent studies have identified angiomotin (Amot) as a
missing link. Amot and angiomotin-like 2 (Amotl2) are homo-
logous membrane-associated Hippo pathway components
that are differentially localized in inside and outside cells: in
inside cells Amot is present throughout themembrane,whereas
in outside cells its localization is apical [61,64]. It has been dis-
covered that loss of Amot leads to nuclear localization of Yap
and, consequently, expression of TE markers in the ICM [64].
This reduces embryo viability during peri-implantation devel-
opment, particularly when both Amot and Amotl2 are
depleted together, indicating that Amot, like Lats1/2, is
required to suppress the TE programme in the ICM. Amot is
an activator of Lats2 [65] and consequently can activate the
Hippo pathway in the embryo [61]. However, Amot has also
been shown to be able to sequester aHippopathway-insensitive
Taz mutant, indicating that Amot can also inhibit Yap/Taz
activity by physical tethering [66]. In agreementwith this possi-
bility, overexpression of Amot can compensate for the loss
of Lats1/2 in the embryo [64]. Because endogenous levels of
Amot do not seem able to suppress the TE programme
in Lats12/2; Lats22/2 mutants [49], this Hippo-independent
action of Amot is unlikely to be dominant. Interestingly, Amot
itself can be phosphorylated by Lats2, which is required for
the activation of the Hippo pathway [61] and could represent
a positive feedback loop between Amot and Lats. As Amot
has a polarizeddistribution in outside cells, itwas hypothesized
that apical polarity determinants may inhibit Amot, allowing
for the TE cell fate. Indeed, PKCl and Par6 are required to
anchor Amot to the apical domain in outside cells [61], and in
their absence Amot distributes uniformly across the membrane
and Yap becomes phosphorylated. Amot is likely to be tethered
to AJs via interaction with Nf2, a Hippo pathway component
[67,68]. Although localization of Nf2 is not polarized in outside
cells, loss of Nf2 phenocopies Amot2/2 and Lats2/2 with
accumulation of Yap in the nucleus of ICM cells and expression
of TE markers [69]. As exogenous Lats2 can rescue the loss of
Nf2phenotype,Nf2 seemstobeupstreamofLats [69].However,
overexpression of either Nf2 or Amot does not suppress the TE
programme in outside cells, unlike overexpression of Lats2
[64,69]. This indicates that high levels of Nf2 or Amot cannot
overcome the inhibition posed by apical polarity factors and
that this does not apply to Lats. Moreover, outside cells actively
degrade Amot, which does not occur in inside cells [64]. Thus,
multiple regulatory factors in outside cells are involved in regu-
latingCdx2 expression to establish theTE fate programme in the
mouse embryo.
These findings lead us to propose a model of how the TE
and ICM are specified in a compact embryo containing outside
inside (embryonic)outside (extraembryonic)
Nf2
Par6 aPKC
E-cadherin
Amot/Amotl2Amot/Amotl2
Yap/Taz
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Cdx2
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Figure 2. Specification of the TE and ICM. The compacted morula is the earliest point where blastomeres have differential spatial positioning. Blastomeres on the
inside of the embryo encounter symmetric cell– cell contact and give rise to the pluripotent ICM. Outside cells have asymmetric cell–cell contact and form the
extraembryonic TE. The asymmetry in cell– cell contact leads to accumulation of polarity proteins such as Par6 and aPKC at the apical domain. Par6 and aPKC activity
inhibits activity of Amot and the Hippo pathway kinases Lats1/2. As a result, Yap and Taz are de-repressed, Tead4 transcriptional activity is switched on and Cdx2
expression and the TE cell fate programme are activated. In inside cells, symmetric cell– cell contact prevents establishment of an apical domain. Amot is active and
is likely tethered to AJs through a putative Nf2–a-catenin–b-catenin–E-cadherin complex. Amot sequesters Yap/Taz to the cytoplasm as well as activating the
Hippo pathway proteins Lats1/2. Lats1/2 can inhibit Yap/Taz activity via the canonical Hippo pathway and can also activate Amot in a positive feedback loop. In the
absence of Yap/Taz in the nucleus, Tead4 activity is switched off, Oct4 expression is promoted and the default pluripotent programme is expressed. Therefore,
positional and polarity cues in these two populations lead to changes in gene regulation and differentiation into their respective lineages.
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5and inside cells (figure 2). On the surface of the embryo, asym-
metric cell–cell contact leads to the establishment of an apical
domain, characterized by the Par3/Par6/aPKC complex. In the
presence of apical polarity, the TE fate suppressors Amot and
Lats are anchored to the apical domain and their activities
are inhibited. Yap and Taz are allowed to enter the nucleus
to activate Tead4 target genes, such as Cdx2, and consequently
the TE fate programme is switched on. In the centre of the
embryo, uniform cell–cell contact prevents the establishment
of an apical domain in inside cells. This allows Amot and Lats
to interact with AJs, probably through Nf2, and become acti-
vated. Yap and Taz are retained in the cytoplasm and Tead4
remains switched off. In the absence of Tead4 activity, the
cells continue to express ICM markers and take on an ICM
fate. In this way, the separation of two distinct cell populations
that differ in both position and polarity allows for differential
gene regulation and the specification of two different cell fates.
(c) Segregation of the inner cell mass into embryonic
epiblast and primitive endoderm
Traditionally, the segregation of the TE versus the ICM and
the PE versus the EPI have been regarded as two separatecell fate decisions, however it is becoming clear that they
are not independent. Precursors of the PE and EPI can be
identified in the ICM by E3.5 when they start to activate
unique transcriptional programmes [13,70]. EPI cells express
pluripotency genes such as Nanog [38,71] and Sox2 [39],
while PE cells activate an endodermal transcriptional net-
work characterized by the expression of Gata6 [72], Gata4
[72], platelet-derived growth factor receptor alpha [15],
Sox17 [73] and Sox7 [74]. The precursor cells are then
sorted into the correct position for each lineage by a combi-
nation of active cell migration, positional induction and
programmed cell death of incorrectly positioned cells
[14,15]. By E4.5, the EPI occupies the deeper ICM compart-
ment and PE cells line the surface of the ICM next to the
blastocyst cavity. Nanog is the first gene to be specifically
expressed in EPI cells and without its expression, the EPI
fails to develop [75]. These Nanog2/2 embryos were also
found to lack PE, suggesting that a signal provided by EPI pre-
cursor cells is critical to promote PE development. Fgf
signalling has been uncovered as essential for PE fate specifica-
tion [32,34]. EPI precursor cells in the early ICM upregulate
expression of Fgf4, which is important for maintaining
the PE fate programme in PE precursor cells, most likely by
wave 1 asymmetric divisions
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inner cell
Fgf4
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Fgfr2
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Figure 3. Specification of the EPI and PE. ICM cells internalized in the first
wave of asymmetric cell divisions upregulate Fgf4, while cells internalized in
the second wave express higher levels of Fgfr2, possibly by inheriting this
transcription factor from their outside 16-cell stage mother cells. Fgf signal-
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6inhibiting the repression of Gata6 expression byNanog [32,76].
As well as Nanog, Oct4, expressed throughout the ICM, is
required for the expression of Fgf4 in EPI precursor cells and
also for a newly discovered cell-autonomous role in the acti-
vation of PE gene expression [77]. The levels of Fgf signalling
within the ICM are therefore critical for creating the correct
balance of EPI and PE precursor cells (figure 3).
The generation of a mature ICM containing the appropri-
ate number of EPI and PE cells is crucial for subsequent
development. It has been recently demonstrated that despite
the regulative ability of the preimplantation embryo, a mini-
mum of four EPI cells has to be established by E4.5 for
development to successfully progress beyond implantation
[36]. Thus, the plasticity of ICM cells provides back-up mech-
anisms for maintaining this critical balance of ICM cell fate
specification. The number of inside cells generated by each
wave of asymmetric cell divisions is regulated such that
each embryo will end up with roughly the same number of
ICM cells: those with few cells internalized in the first wave
will have more internalized in the second wave, and vice
versa [2]. As cells internalized early switch on Fgf4, while
those internalized later inherit higher levels of Fgfr2 from
their outside parents [33,35], the amounts of Fgf ligand and
receptor in the ICM is therefore modulated by the specific
number of ICM cells generated in each wave. In embryos
with few wave-one-derived inside cells, the levels of Fgf sig-
nalling are low resulting in only those wave-two-generated
cells expressing high Fgfr2 forming PE. In embryos with
many wave-one-derived inside cells, there is a high level of
Fgf4 in the ICM which promotes the PE development of
some wave-one-derived cells with lower levels of Fgfr2. In
this way, the balance of EPI and PE remains the same regard-
less of the initial ICM composition. Interestingly, EPI
precursors seem to have a more restricted cell fate potential
than PE precursors [78]. It has been suggested that ICM
cells internalized later in development inherit a greater flexi-
bility and an increased ability to respond to differentiation
cues than those internalized earlier due to exposure to the
TE fate programme in outside cells [35]. In agreement with
this flexibility, PE cells have been shown to not only contrib-
ute to extraembryonic lineages but also to some embryonic
tissues after implantation [79]. These findings demonstrate
the close relationship between the first two cell fate decisions
and how the embryo is prepared for implantation through
the concerted effects of gene expression, cell position, cell
polarity and signalling on a highly flexible cell population.ling in wave two cells inhibits the repression of Gata6 expression by Nanog,
biasing these cells towards the PE lineage.3. Pre- to postimplantation transition: from
blastocyst to egg cylinder
(a) Blastocyst implantation
When all three preimplantation cell lineages have been
segregated, the blastocyst enters the uterus and hatches out
of the zona pellucida. This process is a natural selection
checkpoint as it permits the developmental progress only of
embryos that are able to hatch. Within the next hours, the
hatched blastocyst invades the maternal tissues and implants.
Ovarian oestrogen and progesterone synchronize the timing
of uterine receptivity with embryo development to ensure
successful implantation and the level of oestrogen deter-
mines the duration of the implantation window withinwhich the implantation process can occur [80]. The process
of implantation can be divided into three phases: apposition,
attachment and penetration. During the apposition phase, the
diameter of the uterine lumen becomes reduced to position
the floating embryo close to the luminal epithelium (LE).
The first contact between the embryo and the mother is
mediated by interdigitation of TE and LE microvilli, but
this is insufficient for stable attachment. An anti-adhesive
glycoprotein layer of mucins covers the uterine surface and
serves as a barrier against pathogens. At the time of uterine
receptivity, this layer is removed under the control of
maternal hormones and actively by the embryo [81,82].
Only then does the combined effect of a variety of adhesion
(a)
(b)
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EP
I
egg cylinder (E5.5)
blood vessels
luminal epithelium
uterine lumen
decidua
Figure 4. Implantation and signalling during egg cylinder formation. (a) After hatching, blastocyst adheres to the LE and invades the stroma at the antimesometrial
site of the uterus. In response, the stromal cells differentiate into decidual cells that regulate trophoblast invasion, enable nutrients and gas exchange and ensure
fetomaternal immune tolerance. In the next 24 h, the decidua rapidly proliferates to support embryo development into the egg cylinder and beyond. (b) The EPI
cells secrete Fgf4 ligand that binds to Fgfr2 in the ExE in a paracrine manner. Active Fgfr2 signalling promotes Cdx2 and Eomes expression and inhibits genes
associated with TS cell differentiation such as Mash2. Nodal produced in the EPI promotes ExE maintenance directly by activating core TS cell genes and indirectly
by sustaining Fgf4 expression. In turn, ExE potentiates Nodal activity by secreting furin and PACE4 proteases that cleave out the Nodal propeptide to generate a
mature ligand with higher activity.
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7systems such as integrins and cadherins at the interface
between the TE and LE mediate stable attachment of the
embryo [83,84]. This direct contact induces apoptosis of LE
at the site of attachment, allowing penetration of the TE
into the endometrial stroma [85,86]. The embryo inva-
des the antimesometrial site of the uterus with the ICM
oriented towards the mesometrial pole (figure 4a). The sur-
rounding stromal cells proliferate and differentiate into
polyploid decidual cells [87] and the decidua supports the
development of the embryo by enabling nutrients and gas
exchange, ensuring fetomaternal immune tolerance by restrict-
ing the entry of cells of the immune system and regulating TE
invasion [88,89].
In mouse, the mural TE (that surrounds the blastocyst
cavity) makes the first contact with maternal tissues and sub-
sequently differentiates into primary TE giant cells (TGCs).
This is the first terminally differentiated cell type generated
during prenatal development. Leading implantation, TGCs
invade the uterine stroma and secrete factors such as pro-
gesterone and type I interferon that promote decidual cell
differentiation [90,91]. Local vasculature remodelling andangiogenesis are induced at the implantation site by TGC
subtypes to mediate nutrient, waste and gas exchange
between the growing embryo and the mother [92]. In contrast
to the terminal differentiation fate of the mural TE cells, the
polar TE, which surrounds the outer surface of the ICM, is
the source of multipotent progenitors—the TE stem (TS)
cells. Following implantation, the polar TE proliferates and
differentiates into the extraembryonic ectoderm (ExE) and
ectoplacental cone (EPC) that build the proximal half of
the egg cylinder, and later the placenta. TE differentiation
depends on the T-box transcription factor Eomes, which
functions downstream of Cdx2 in the TE fate programme.
Accordingly, Eomes inactivation results in failure of the TE
differentiation programme and developmental arrest at E4.5
[40,42]. After implantation, a self-renewing TS cell population
is maintained in the ExE compartment that provides progeni-
tors to the EPC. The maintenance of this stem cell pool in the
ExE depends on expression of Elf5 that is in a positive feedback
loop with Cdx2 and Eomes. In the absence of Elf5, Cdx2 and
Eomes are shut down, leading to rapid depletion of the multi-
potent TE cells and loss of ExE by E5.5 [93,94]. Ets2 promotes
rstb.
8the Elf5/Cdx2/Eomes expression circuit within the ExE.
Accordingly, Ets2 knockout embryos implant but show
severely reduced development of the TE lineages [95,96].royalsocietypublishing.org
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369:20130538(b) Initiation of proliferation following implantation
While during preimplantation development cleavage div-
isions generate progressively smaller blastomeres with
constant total volume, following implantation a burst of cell
proliferation initiates growth. This growth results in the
expansion of embryonic and extraembryonic lineages into
the blastocyst cavity around E5.0. At the same time, motile
parietal endoderm cells come to line the internal surface of
the mural TE, sandwiching a basement membrane layer
(Reichert’s membrane). Visceral endoderm cells derived
from the PE cover both the EPI and ExE compartments of
the elongating egg cylinder. As a result of this growth and
reorganization, the embryo adopts a new shape within just
24 h following the initiation of implantation. Several signal-
ling pathways have been uncovered as essential for the
growth and survival of the embryo following implantation.
The mammalian target of rapamycin (mTOR) regulates cell
growth by integrating upstream signals of growth factors
and amino acids. Cell proliferation is severely affected in all
lineages of mTOR knockout embryos and they fail to pro-
gress beyond E5.5 [97,98]. Growth factors such as Igf and
insulin promote cell growth by activating mTOR, through
the PI3K/Akt pathway [99]. Genetic ablation of the p110b
regulatory subunit, essential for the activity of the class IA
PI3K, results in lethality during late pre- and early post-
implantation stages [100]. Severe growth retardation and
substantially reduced mTOR activity are observed in class 3
PI3K (PI3KC3) knockout embryos that die shortly after
implantation [101]. In vitro, embryonic stem (ES) cell-specific
Ras-like protein ERas activates PI3K to sustain ES cell pro-
liferation. Upon xenotransplantation, ERas functions as an
oncogene essential for the tumourigenic potential of ES
cells [102]. Targeted disruptions of an array of genes associ-
ated with cancer in adult tissues result in early embryonic
lethality, indicating an importance of genome integrity and
cell survival during early embryogenesis. For example, loss
of Brca1 and Brca2, associated with breast and ovarian can-
cers, leads to death at early postimplantation stages due to
inhibited cell proliferation [103–107].
Egg cylinder growth, organization and primitive streak
formation to initiate gastrulation require ActRIB (activin
type I), ActRIIA and ActRIIB (activin type II) receptor sig-
nalling [108,109]. Several TGFb family ligands, such as
Activin, Nodal and the mammalian Vg1 homologues
GDF1 and 3, can bind these receptors. The activated recep-
tors phosphorylate Smad2/3 that complex with Smad4
and translocate into the nucleus to activate target gene
expression [110,111]. Smad2/3 and 4 are ubiquitously
expressed and function as tumour suppressors in adult tis-
sues [112]. The disruption of Smad2 or Smad4 causes
defects in egg cylinder elongation and mesoderm induction
[113,114]. Bone morphogenetic protein (BMP) ligands, such
as BMP4, activate another branch of TGFb signalling through
the Smad1/5/8 pathway. BMP4 signalling is critical for EPI
proliferation, mesoderm formation and induction of primor-
dial germ cell fate [115,116]. The rapid proliferation and
organization of embryonic and extraembryonic tissues follow-
ing implantation is therefore regulated by the coordinatedactivity ofmultiple signalling pathways and extensive crosstalk
between different cell types.(c) Development of the trophoblast
TS cells can be derived in culture from polar TE or ExE
explants up to E8.5 [117,118]. TS cell proliferation and self-
renewal in vitro requires the presence of Fgf4 and embryonic
fibroblast conditioned medium [117]. Activin or TGFb can
replace the conditioned medium, although these factors are
dispensable for the maintenance of the TS cell population
in the embryo [119]. In vivo Fgf4 and Nodal signalling cross-
talk between the ExE and the EPI enables the synchronous
development of the egg cylinder (figure 4b). EPI cells produce
Fgf4 that binds to Fgfr2 on the surface of the TE cells; loss
of key components of the Fgf signalling pathway results in
peri-implantation lethality due to failures not only in PE spe-
cification but also in TE maintenance [13,120–123]. Fgfr2
signalling controls TE cell survival through the downstream
Shp2 phosphatase that triggers the Sfk/Ras/Erk signalling
cascade. Erk1/2 kinases phosphorylate and target for degra-
dation the pro-apoptotic protein Bim and a failure to activate
Erk in Shp2 knockout embryos results in peri-implantation
lethality and TS cell death in vitro even in the presence of
Fgf4 [124]. Expression of genes essential for the maintenance
of multipotent TE progenitors is also dependent on Fgf sig-
nalling. For example, the membrane-linked docking protein
Frs2a is phosphorylated in response to Fgf4 stimulation of
Fgfr2 that activates the downstream Erk cascade and promo-
tes Cdx2 expression. Cdx2 in turn binds to the responsive
enhancer element of the Bmp4 promoter and upregulates
Bmp4 expression [125,126]. Bmp4 produced in the ExE has
been reported to act as a paracrine factor essential for
proper EPI development after implantation [116]. Thus,
Fgf4 signals transmitted between the distal and proximal
parts of the egg cylinder cross-regulate directly and indirectly
the maintenance and differentiation of the embryonic and
extraembryonic lineages.
Fgf4 expression in the EPI is maintained by Nodal, a
member of the TGFb ligand superfamily that binds to type
I and type II receptor dimers that, in turn, activate the down-
stream Smad2/Smad3 signalling cascade [111]. Nodal is
secreted from EPI cells as a propeptide that is proteolytically
processed extracellularly by proteases secreted by the ExE:
furin (SPC1) and PACE4 (SPC4) [127]. Thus, while matu-
ration of Nodal is under ExE control, Nodal signalling
promotes ExE maintenance indirectly by sustaining Fgf4
expression in the EPI that, in turn, activates Fgfr2 signalling
in the ExE. This results in the sustained expression of TS
cell markers such as Cdx2, Eomes and Err2 and suppression
of differentiation markers such as the paternally imprinted
geneMash2. Nodal also acts directly on the ExE in a paracrine
manner, alongside Fgf4, to maintain the self-renewing popu-
lation of TS cells. Accordingly, loss of Nodal or its
convertases furin and PACE4 drives differentiation of the
ExE towards an EPC fate [128].
The stem cell pool of the ExE contributes to the EPC that
later gives rise to the spongiotrophoblast and secondary
TGCs [129,130]. The basic helix-loop-helix (bHLH) transcrip-
tion factor Mash2 regulates TGC differentiation in the EPC
[131–133]. In TS cells, Mash2 is upregulated by nuclear Sp1
that binds a consensus Sp1 binding motif in the Mash2 pro-
moter. Activation of the PI3K/Akt pathway by TSSC3 leads
rstb.royalsocietypublishing.org
9to Sp1 nuclear translocation and Mash2 upregulation [134].
TGC differentiation requires Mash2 silencing by the poly-
comb group protein Eed and therefore ablation of Eed leads
to permanent expression of Mash2 in the EPC and, conse-
quently, reduced differentiation into secondary TGCs [135].
Low numbers of TGCs are also found in embryos deficient
for the bHLH repressor I-mfa, proposed to inhibit Mash2
by preventing nuclear import and DNA binding [136].
Other bHLH transcription factors, such as Hand1 and
Stra13, can override the inhibitory effects of Fgf4 signalling
in TS cells and directly promote TGC differentiation [137].Phil.Trans.R.Soc.B
369:20130538(d) Epiblast morphogenesis
A global reorganization of the EPI during the peri-implan-
tation stages reshapes it from a compact ball of non-
polarized cells into a cup-shaped polarized epithelium sur-
rounding the pro-amniotic cavity. The emergence of this
new organization of the pluripotent EPI provides the foun-
dation for patterning and specification of the germ lineages
that build the embryo proper. There are two major paths
that can be followed to establish luminal space: hollowing
and cavitation. In the process of cavitation, programmed
cell death eliminates the inner cells of a solid cohort, generat-
ing an empty space. Hollowing, in contrast, does not require
apoptosis but organized radial polarization and separation of
apical membranes to form a central lumen [138,139]. Embry-
oid bodies (EBs) have been commonly used as an accessible
in vitro model that recapitulates many aspects of embryonic
development. Studies of aggregates of ES cells or embryo-
nic carcinoma cells grown in suspension indicated that
apoptosis of the cells in the core of EBs is required for
cavity formation [140] with BMP and Rac1 signalling pro-
posed to promote the elimination of inside cells and the
survival of cells contacting the basement membrane, respect-
ively [141,142]. Although EBs are a valuable in vitro model,
they lack proper embryonic organization and therefore may
not be able to recapitulate the physiological processes that
occur in vivo. For example, EBs and embryos differ in their
initial cell number. While EBs contain a few hundreds
of cells on the first day of culture, the EPI of the implanting
blastocyst consists of only 8–16 cells [36,143]. The second
difference is timing. While cavitation and the establishment
of polarized epithelium in EBs is a slow process that takes
several days, the blastocyst to egg cylinder transition occurs
in vivo within a 24 h period beginning at E4.5 [144]. Thus,
the large number of slowly polarizing cells in the EBs
may induce apoptotic-mediated cavitation, as indeed is obser-
ved in high-density culture of MDCK cells in the absence of
strong polarization cues. By contrast, low-density MDCK cells
efficiently polarize and form lumens within 2 days through
a process of hollowing that does not require cell death. There-
fore, cells can use different mechanisms for lumen formation
depending on the polarization efficiency [145].
With an aim to understand how the EPI is reorganized
during peri-implantation stages, we have established an
in vitro environment that supports development from the
preimplantation blastocyst to the postimplantation egg
cylinder stage [146]. This has allowed us to reveal the mor-
phogenetic steps taken by the embryo at its pre- to post-
implantation transition [147]. Using a cell death reporter
and genetic and pharmacological approaches to inhibit cell
death, we have found that apoptosis is not required for EPImorphogenesis and pro-amniotic cavity generation. More-
over, there are no signs of cell death in the region where
the cavity would form in either peri-implantation embryos
cultured in vitro or recovered from mothers. To reveal any
alternative mechanism for cavity formation, we followed
the organization of EPI cells at the time of pre- to post-
implantation transition [147]. This revealed that the EPI
becomes reorganized from a ball of unpolarized cells into a
highly organized rosette-like structure at the time of implan-
tation, a process involving drastic changes in cell shape and
polarization (figure 5). This reorganization appears to be a
result of apical constriction mediated by contraction of the
actomyosin network linked to AJs. As cells acquire a polar-
ized epithelial morphology, actin filaments accumulate
apically and the Golgi apparatus and nucleus localize sub-
apically and basally, respectively. As development pro-
gresses, a single lumen emerges in the centre of the rosette
[140]. Lumen formation is likely to be a result of membrane
separation through charge repulsion as the apical domains
facing the lumen express the highly negatively charged sialo-
mucin podocalyxin (PCX) involved in lumen formation in
glomerular and MDCK cells [148,149]. Thus, formation of a
polarized rosette is the first morphogenetic step that reshapes
the EPI during implantation and serves to provide a foun-
dation for the emerging egg cylinder.
But what triggers the self-organization of EPI cells into a
highly polarized rosette? Our results indicate that this is
mediated by extracellular matrix (ECM) signalling through
integrin receptors to direct cell polarization [147]. ECM pro-
teins, such as laminin secreted by the PE and TE, assemble
a basement membrane that envelopes the EPI of the implant-
ing blastocyst. The function of this basement membrane can
be mimicked in vitro by embedding ICMs in matrigel, leading
to the formation of polarized EPI-like structures with a cen-
tral lumen. The basement membrane therefore could be
seen as creating a niche that provides polarization cues to
the maturing EPI [147]. This is consistent with laminin and
integrin functions in the early embryo as elimination of the
laminin-g1 subunit leads to a failure to assemble the base-
ment membrane, resulting in peri-implantation lethality
[150], and elimination of b1-integrin receptor leads to EPI
defect following implantation [151,152]. Strikingly, it appears
that the process of EPI morphogenesis can be mimicked in
vitro by embedding small clumps of ES cells into three-
dimensional ECM gels. The ECM proteins trigger polariz-
ation and lumenogenesis through b1-integrin receptors and,
as in the peri-implantation EPI, the cells change shape and
constrict apically within the centre of the ES cell sphere. A
single PCX-coated lumen emerges in the centre of the radially
arranged cells, resembling the morphogenesis following
implantation [147].
Overall, the discovery of the self-organizing properties of
pluripotent EPI cells leads to a new model of the morpho-
genetic steps of the blastocyst to egg cylinder transition
(figure 5). It proposes that prior to implantation (E4.5), the
extraembryonic lineages of the late blastocyst consist of polar-
ized epithelial cells that secrete ECM proteins, which
assemble a basement membrane that wraps around the EPI.
This basement membrane creates a niche where ECM com-
ponents are sensed by integrin receptors on the surface of
the EPI. The niche provides polarization cues that orient the
apical–basal axis of the EPI cells. Actomyosin constriction
and accumulation of apical determinants of the Par complex
E3.5 E4.5 E4.75
peri-implantation>> preimplantation postimplantation >>
E5.0
apical
domain
basal
domain
lumen
EPI polar TE/ExE PE/VE basement membrane apical domain lumen/proamniotic cavity
E5.25 E5.75E5.5late E4.5
Figure 5. Model of peri-implantation morphogenesis. Following preimplantation lineage segregation (E3.5–E4.5), the extraembryonic lineages start secreting ECM
proteins that assemble a basal membrane that wraps around the EPI and provides polarization cues through integrin receptors. During the peri-implantation period
(late E4.5–E5.0), the pluripotent EPI cells establish apical–basal polarity, change shape and constrict apically while clustering to form a rosette. A central lumen
emerges in the centre of the rosette through hollowing of apical membranes by charge repulsion (E5.0–E5.25). As the egg cylinder elongates the lumen enlarges
and incorporates intramembranous spaces of the proximal ExE to form the mature pro-amniotic cavity (E5.5–E5.75).
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10reorganize the EPI into a radially polarized rosette-like struc-
ture (E4.75–E5.0). Among other proteins, anti-adhesive
molecules such as PCX are delivered to the apical surfaces
in the centre of the rosette and, as a result, membrane repul-
sion leads to hollowing and a central lumen emerges. A
similar process of polarization and hollowing is likely to
occur in the ExE with both lumens then merging to form
the mature pro-amniotic cavity (E5.5–E5.75). The lumen
enlarges as the egg cylinder elongates and active processes
of exocytosis and pumping can also potentiate accumulation
of fluid leading to pro-amniotic cavity expansion. As the egg
cylinder enlarges, the basement membrane separating the EPI
and the ExE is no longer maintained. Thus, the basement
membrane resembles a basket, structurally linked to the EPI
cells through integrin-mediated contacts, acting as a mould
to direct the shape of the EPI, transforming it from asymmetric hollowed sphere into a cup, building the distal
part of the mature egg cylinder.(e) Concluding remarks
Implantation is a unique property of mammalian embryo
development and the morphogenetic processes driving the
pre- to postimplantation transition have only recently begun
to be understood. As imaging of developmental dynamics
and individual cell-tracking techniques improve, so does our
understanding of how the early embryo prepares the necessary
cell types for implantation and then transforms itself to initiate
development of the embryo proper.
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